Member Info for JamesHigz

Yeah agree with 21ATS, with the lack of movement from SP on ASTR I can only assume it’s due to lack of understanding on what a bittensor actually is or the subcontract for ASTR ‘sigma arena’ Is extremely volatile?

Please explain then notready1 I’m all ears 😂

Please explain

I agree with you 21ATS I am none the wiser however, I have been learning a lot from YouTube (link below) follow his page a he good is good at explaining:

https://youtu.be/aoAiV4frT-M

For what it’s worth I will try answer your questions:

1) Sigma Arena is a decentralised company which could be easily replaced but another subnet. This is not infinite as subnets are created everyday as it stands our subnet (1 particular model of AI infrastructure (data checking) RNS from ASTR - ‘’SigmaArena is designed to support the creation and testing of autonomous AI systems that can make and adapt trading decisions in real ’’ - what I don’t know is the subnet made up of our appointed minors can they be replaced? Is it just our minors are very efficient right now but a new strategy can easily be thought off…

Can anyone clever then me try to add to this?

Too add to this, bittensor 127 (sigma arena) is one of the modules use to generate ai. But what I’m confused about is what makes sigma arena popular to use? Surely if it’s decentralised then another company on the bittensor could quickly replace sigma arena due to efficiency of data collection? Just trying to wrap my head around it all as I was in it from the start with cannabinoid products which was much easier lol. Trying to understand if averaging down while it’s low is worth it.

With the bittensor TAO halving expected in December will have significant impact against subnet minors for example ASTR.PL. It’s assumed that TAO rewards will be impacted as the halving will cause less mining of that tao coins? Still trying to get my head round it but is that correct?

Oh says sale on mine?

Some big sales landing today, not looking good

Same, just purchased another 400,000 shares. Not quite your number but got to be in it. Let’s go 📈

Can anyone confirm if the 20mil buy was mms or the appointed director? still in with 12k£. buy out is 5p been an emotional roller coaster over last 3 years. Struggling to see how a cannabis pharmaceutical company can use AI to benefit them to be honest.

I've been an investor from the IPO 2 years ago and got stung investing when it launched at 20p and spiked down to 12p in matter of days. At this point I thought it would wise to leave and hopefully come good. Two years on still here and managed to avg down to 5p. Whoever has been here from the beginning knows the tough journey we've been on - like to think this company can claw it back. From the amazon reviews the products are good - I'm hoping sales have picked up with Debenhams launch in October. With the last 2 years being as poor as they have been I like to think this is our year and hopefully the investors who have been in the beginning can see some profit.